Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.02M Buy
31,306
+2,242
+8% +$262K 0.2% 120
2026
Q1
$3.5M Buy
29,064
+1,935
+7% +$223K 0.17% 152
2025
Q4
$2.86M Sell
27,129
-11,759
-30% -$1.1M 0.14% 174
2025
Q3
$3.26M Buy
38,888
+2,803
+8% +$231K 0.13% 187
2025
Q2
$2.86M Buy
36,085
+4,432
+14% +$352K 0.13% 155
2025
Q1
$2.84M Buy
31,653
+5,071
+19% +$473K 0.16% 166
2024
Q4
$2.64M Buy
26,582
+3,489
+15% +$360K 0.16% 152
2024
Q3
$2.62M Sell
23,093
-1,810
-7% -$215K 0.17% 151
2024
Q2
$3.08M Buy
24,903
+1,276
+5% +$164K 0.21% 122
2024
Q1
$3.12M Buy
23,627
+384
+2% +$47.3K 0.23% 111
2023
Q4
$2.53M Sell
23,243
-58
-0.2% -$6.02K 0.2% 129
2023
Q3
$2.4M Sell
23,301
-8,492
-27% -$915K 0.22% 123
2023
Q2
$3.67M Buy
31,793
+4,401
+16% +$500K 0.28% 97
2023
Q1
$2.91M Buy
27,392
+2,133
+8% +$230K 0.24% 111
2022
Q4
$2.8M Buy
25,259
+1,259
+5% +$129K 0.27% 90
2022
Q3
$2.07M Buy
24,000
+561
+2% +$50.1K 0.24% 119
2022
Q2
$2.14M Buy
23,439
+178
+0.8% +$15.8K 0.24% 96
2022
Q1
$1.91M Buy
23,261
+141
+0.6% +$11.1K 0.19% 119
2021
Q4
$1.77M Sell
23,120
-1,684
-7% -$134K 0.17% 166
2021
Q3
$1.86M Sell
24,804
-755
-3% -$57.4K 0.21% 151
2021
Q2
$1.99M Buy
25,559
+3,430
+16% +$255K 0.23% 137
2021
Q1
$1.63M Buy
22,129
+13,349
+152% +$985K 0.21% 146
2020
Q4
$685K Sell
8,780
-420
-5% -$32.1K 0.12% 215
2020
Q3
$703K Buy
+9,200
New +$721K 0.14% 192

Other funds holding MRK

PFG Advisors's MRK Position: Q2 2026 in Review

PFG Advisors increased its Merck (MRK) stake by 7.7% in Q2 2026, buying an estimated $262K and bringing the position to 31,306 shares worth $4.02M. The position accounts for 0.2% of the portfolio, ranked #120.

PFG Advisors first reported a position in MRK in Q3 2020 and has held it in 24 quarters since. 1,554 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • PFG Advisors held 31,306 shares of Merck worth $4.02M as of Q2 2026.
  • PFG Advisors bought 2,242 Merck shares in Q2 2026, an estimated $262K.
  • Merck made up 0.2% of PFG Advisors's portfolio in Q2 2026, its #120 holding.
  • PFG Advisors first reported a position in Merck in Q3 2020 and has held it in 24 quarters since.
  • 1,554 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on PFG Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.